Thirumalai Chemicals Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Thirumalai Chemicals.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals	22.8%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

We Think Thirumalai Chemicals (NSE:TIRUMALCHM) Has A Fair Chunk Of Debt

Dec 24

Revenues Not Telling The Story For Thirumalai Chemicals Limited (NSE:TIRUMALCHM)

Nov 29

Thirumalai Chemicals' (NSE:TIRUMALCHM) Dividend Will Be Reduced To ₹1.00

Jul 12

Investors Still Aren't Entirely Convinced By Thirumalai Chemicals Limited's (NSE:TIRUMALCHM) Revenues Despite 32% Price Jump

Jul 05

Thirumalai Chemicals (NSE:TIRUMALCHM) Will Pay A Smaller Dividend Than Last Year

Jun 28

Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Stock Rockets 28% But Many Are Still Ignoring The Company

Apr 13

Here's What's Concerning About Thirumalai Chemicals' (NSE:TIRUMALCHM) Returns On Capital

Aug 30

Thirumalai Chemicals (NSE:TIRUMALCHM) Is Paying Out Less In Dividends Than Last Year

Jul 07

Capital Allocation Trends At Thirumalai Chemicals (NSE:TIRUMALCHM) Aren't Ideal

Mar 07

Thirumalai Chemicals (NSE:TIRUMALCHM) Is Paying Out A Larger Dividend Than Last Year

Jul 16

Thirumalai Chemicals' (NSE:TIRUMALCHM) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 02

Does Thirumalai Chemicals (NSE:TIRUMALCHM) Have A Healthy Balance Sheet?

Jan 31

Investors Shouldn't Overlook The Favourable Returns On Capital At Thirumalai Chemicals (NSE:TIRUMALCHM)

Oct 12

Trade Alert: Sujatha Sampath At Thirumalai Chemicals Limited (NSE:TIRUMALCHM), Has Just Spent ₹997k Buying A Small Number of Shares

Mar 04

Can Mixed Fundamentals Have A Negative Impact on Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Current Share Price Momentum?

Mar 02

What Type Of Shareholders Make Up Thirumalai Chemicals Limited's (NSE:TIRUMALCHM) Share Registry?

Feb 15

Are Insiders Buying Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Stock?

Jan 25

Did You Participate In Any Of Thirumalai Chemicals' (NSE:TIRUMALCHM) Incredible 429% Return?

Jan 04

Here's Why Thirumalai Chemicals (NSE:TIRUMALCHM) Has A Meaningful Debt Burden

Dec 14

What Do The Returns On Capital At Thirumalai Chemicals (NSE:TIRUMALCHM) Tell Us?

Nov 23

Is Thirumalai Chemicals Limited's (NSE:TIRUMALCHM) Shareholder Ownership Skewed Towards Insiders?

Oct 23

Shareholders Of Thirumalai Chemicals (NSE:TIRUMALCHM) Must Be Happy With Their 256% Total Return

Sep 18

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Thirumalai Chemicals no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NSEI:TIRUMALCHM - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2024	20,982	-335	-4,955	1,588	N/A
6/30/2024	21,151	-443	N/A	N/A	N/A
3/31/2024	20,831	-388	-5,737	2,371	N/A
12/31/2023	19,875	-312	N/A	N/A	N/A
9/30/2023	20,039	1	-7,831	-1,121	N/A
6/30/2023	20,339	404	N/A	N/A	N/A
3/31/2023	21,322	898	-3,086	541	N/A
12/31/2022	22,841	1,927	N/A	N/A	N/A
9/30/2022	23,171	2,599	2,244	3,621	N/A
6/30/2022	22,221	2,762	N/A	N/A	N/A
3/31/2022	19,982	2,812	3,287	4,023	N/A
12/31/2021	18,021	2,758	N/A	N/A	N/A
9/30/2021	15,787	2,370	3,338	3,900	N/A
6/30/2021	13,694	2,029	N/A	N/A	N/A
3/31/2021	10,857	1,177	1,598	2,208	N/A
12/31/2020	9,804	355	N/A	N/A	N/A
9/30/2020	9,073	-24	1,007	1,895	N/A
6/30/2020	9,082	-90	N/A	N/A	N/A
3/31/2020	10,848	232	369	1,397	N/A
12/31/2019	11,191	385	N/A	N/A	N/A
9/30/2019	11,979	512	-767	556	N/A
6/30/2019	12,927	944	N/A	N/A	N/A
3/31/2019	12,610	1,136	407	2,339	N/A
12/31/2018	12,786	1,355	N/A	N/A	N/A
9/30/2018	12,997	1,753	N/A	N/A	N/A
6/30/2018	12,478	1,685	N/A	N/A	N/A
3/31/2018	13,120	1,704	N/A	808	N/A
12/31/2017	12,921	1,497	N/A	N/A	N/A
9/30/2017	11,947	1,134	N/A	N/A	N/A
6/30/2017	11,450	835	N/A	N/A	N/A
3/31/2017	10,285	707	N/A	1,081	N/A
12/31/2016	9,652	758	N/A	N/A	N/A
9/30/2016	9,214	646	N/A	N/A	N/A
6/30/2016	8,972	333	N/A	N/A	N/A
3/31/2016	9,442	322	N/A	1,257	N/A
12/31/2015	9,254	59	N/A	N/A	N/A
9/30/2015	9,796	-130	N/A	N/A	N/A
6/30/2015	10,313	61	N/A	N/A	N/A
3/31/2015	10,723	-137	N/A	1,536	N/A
12/31/2014	11,462	-186	N/A	N/A	N/A
9/30/2014	11,755	15	N/A	N/A	N/A
6/30/2014	12,716	131	N/A	N/A	N/A
3/31/2014	12,762	119	N/A	1,331	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de TIRUMALCHM es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de TIRUMALCHM crezcan más rápidamente que el mercado Indian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de TIRUMALCHM crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de TIRUMALCHM crezcan más rápidamente que el mercado de Indian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de TIRUMALCHM crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de TIRUMALCHM se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Análisis de la empresa y estado de los datos financieros

Datos	Última actualización (huso horario UTC)
Análisis de la empresa	2025/01/10 20:10
Precio de las acciones al final del día	2025/01/10 00:00
Beneficios	2024/09/30
Ingresos anuales	2024/03/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

Paquete	Datos	Marco temporal	Ejemplo Fuente EE.UU. ^*
Finanzas de la empresa	10 años	Cuenta de resultados Estado de tesorería Balance	Formulario SEC 10-K Formulario SEC 10-Q
Estimaciones del consenso de analistas	+3 años	Previsiones financieras Objetivos de precios de los analistas	Informes de análisis Blue Matrix
Precios de mercado	30 años	Precios de las acciones Dividendos, escisiones y acciones	Datos de mercado ICE Formulario S-1 de la SEC
Propiedad	10 años	Accionistas principales Información privilegiada	Formulario SEC 4 Formulario SEC 13D
Gestión	10 años	Equipo directivo Consejo de Administración	Formulario SEC 10-K Formulario SEC DEF 14A
Principales avances	10 años	Anuncios de empresas	Formulario SEC 8-K

^* ejemplo para los valores estadounidenses, para los no estadounidenses se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Obtenga más información aquí.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en .

Fuentes analistas

Thirumalai Chemicals Limited está cubierta por 2 analistas. 0 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

Analista	Institución
Harini V.	FirstCall Research
Vijay Madunala	FirstCall Research

Thirumalai Chemicals Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Thirumalai Chemicals Limited Announces Resignation of T. Rajagopalan as Company Secretary and Compliance Officer

We Think Thirumalai Chemicals (NSE:TIRUMALCHM) Has A Fair Chunk Of Debt

Revenues Not Telling The Story For Thirumalai Chemicals Limited (NSE:TIRUMALCHM)

Second quarter 2025 earnings released: EPS: ₹0.46 (vs ₹0.59 loss in 2Q 2024)

Thirumalai Chemicals Limited to Report Q2, 2025 Results on Oct 29, 2024

Thirumalai Chemicals Limited Approves Election of Mr. M. Somasundaram as Independent Director

New major risk - Financial position

Thirumalai Chemicals' (NSE:TIRUMALCHM) Dividend Will Be Reduced To ₹1.00

Upcoming dividend of ₹1.00 per share

Thirumalai Chemicals Limited to Report Q1, 2025 Results on Jul 24, 2024

Investors Still Aren't Entirely Convinced By Thirumalai Chemicals Limited's (NSE:TIRUMALCHM) Revenues Despite 32% Price Jump

Full year 2024 earnings released: ₹3.79 loss per share (vs ₹8.77 profit in FY 2023)

Thirumalai Chemicals (NSE:TIRUMALCHM) Will Pay A Smaller Dividend Than Last Year

Dividend reduced to ₹1.00

Thirumalai Chemicals Limited, Annual General Meeting, Jul 24, 2024

New major risk - Dividend sustainability

Full year 2024 earnings released: ₹3.79 loss per share (vs ₹8.77 profit in FY 2023)

Thirumalai Chemicals Limited Recommends Dividend for the Year Ended March 31, 2024

Thirumalai Chemicals Limited to Report Q4, 2024 Results on May 15, 2024

Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Stock Rockets 28% But Many Are Still Ignoring The Company

Third quarter 2024 earnings released: ₹2.24 loss per share (vs ₹0.81 profit in 3Q 2023)

Thirumalai Chemicals Limited to Report Q3, 2024 Results on Jan 24, 2024

Second quarter 2024 earnings released: ₹0.59 loss per share (vs ₹3.35 profit in 2Q 2023)

Here's What's Concerning About Thirumalai Chemicals' (NSE:TIRUMALCHM) Returns On Capital

CFO, MD & Whole-Time Director recently bought ₹989k worth of stock

First quarter 2024 earnings released: EPS: ₹1.04 (vs ₹5.86 in 1Q 2023)

Thirumalai Chemicals Limited to Report Q1, 2023 Results on Jul 22, 2023

Upcoming dividend of ₹1.50 per share at 0.7% yield

Thirumalai Chemicals (NSE:TIRUMALCHM) Is Paying Out Less In Dividends Than Last Year

Thirumalai Chemicals Limited to Report Nine Months, 2024 Results on Feb 14, 2024

Insider recently bought ₹2.8m worth of stock

Chairman & MD recently bought ₹9.1m worth of stock

Thirumalai Chemicals Limited Recommends a Dividend for the Year Ended March 31, 2023

Full year 2023 earnings released: EPS: ₹8.77 (vs ₹27.47 in FY 2022)

CFO, MD & Whole-Time Director recently bought ₹1.5m worth of stock

Capital Allocation Trends At Thirumalai Chemicals (NSE:TIRUMALCHM) Aren't Ideal

CFO, MD & Whole-Time Director recently bought ₹2.5m worth of stock

Third quarter 2023 earnings released: EPS: ₹0.81 (vs ₹7.37 in 3Q 2022)

Insider recently bought ₹5.0m worth of stock

Second quarter 2023 earnings released: EPS: ₹3.35 (vs ₹4.94 in 2Q 2022)

Thirumalai Chemicals Limited to Report Q2, 2023 Results on Oct 26, 2022

Thirumalai Chemicals Limited Appoints Arun Alagappan as an Independent Director

Thirumalai Chemicals Limited to Report Q1, 2023 Results on Jul 27, 2022

Thirumalai Chemicals (NSE:TIRUMALCHM) Is Paying Out A Larger Dividend Than Last Year

Upcoming dividend of ₹2.50 per share

Full year 2022 earnings released: EPS: ₹27.47 (vs ₹11.49 in FY 2021)

Thirumalai Chemicals Limited to Report Q2, 2022 Results on Nov 15, 2022

Thirumalai Chemicals' (NSE:TIRUMALCHM) Shareholders Will Receive A Bigger Dividend Than Last Year

Thirumalai Chemicals Limited, Annual General Meeting, Jul 27, 2022

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹27.47 (vs ₹11.49 in FY 2021)

Thirumalai Chemicals Limited Recommends A Dividend for the Year Ended March 31, 2022

Investor sentiment improved over the past week

Does Thirumalai Chemicals (NSE:TIRUMALCHM) Have A Healthy Balance Sheet?

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Chairman & MD recently bought ₹4.0m worth of stock

Second quarter 2022 earnings released: EPS ₹4.94 (vs ₹1.61 in 2Q 2021)

Investors Shouldn't Overlook The Favourable Returns On Capital At Thirumalai Chemicals (NSE:TIRUMALCHM)

Insider recently sold ₹1.7m worth of stock

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Estimating The Intrinsic Value Of Thirumalai Chemicals Limited (NSE:TIRUMALCHM)

Upcoming dividend of ₹2.20 per share

Investor sentiment improved over the past week

Thirumalai Chemicals (NSE:TIRUMALCHM) Could Easily Take On More Debt

Full year 2021 earnings released: EPS ₹11.49 (vs ₹2.26 in FY 2020)

Insider recently sold ₹269k worth of stock

Full year 2021 earnings released: EPS ₹11.49 (vs ₹2.26 in FY 2020)

Thirumalai Chemicals Limited Recommends Dividend for the Financial Year Ended March 31, 2021

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Be Wary Of Thirumalai Chemicals (NSE:TIRUMALCHM) And Its Returns On Capital

Insider recently bought ₹997k worth of stock

Trade Alert: Sujatha Sampath At Thirumalai Chemicals Limited (NSE:TIRUMALCHM), Has Just Spent ₹997k Buying A Small Number of Shares

Can Mixed Fundamentals Have A Negative Impact on Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Current Share Price Momentum?